Literature DB >> 1717222

Treatment principles for the use of opioids in pain of nonmalignant origin.

S A Schug1, A F Merry, R H Acland.   

Abstract

Inadequately treated acute and chronic pain remains a major cause of suffering, in spite of enormous advances in pharmacology and technology. Opioids provide a powerful, versatile, widely available means of managing this pain, but their use is too often restrained by ignorance and mistaken fears of addiction. The management of postoperative pain (perhaps the most common form of acute pain) is traditionally attempted with fixed dosages of analgesics by relatively unpredictable routes (e.g. oral, rectal and intramuscular). Intravenous opioid infusions (an improvement) risk respiratory depression and require close monitoring and titration. Patient-controlled analgesia (PCA), by contrast, permits the most efficacious medication (pure opioid agonist) by the optimal route (intravenous) under direct control of the patient, and provides high levels of satisfaction and safety. Ideally, any opioid use should be integrated with a wide spectrum of other analgesic modalities in an anaesthesiology-based 'acute pain service'. The use of opioids for chronic pain of nonmalignant origin remains controversial. There is a perceived conflict between patients' interests and those of society. However, problems (such as tolerance, physical dependence, addiction and chronic toxicity), anticipated from experience with animal experiments and pain-free abusers, seldom cause difficulties when opioids are used appropriately to treat pain (so-called 'dual pharmacology'). With sensible guidelines, and in the context of a multidisciplinary pain clinic, opioids may provide the only hope of relief to many sufferers of chronic pain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717222     DOI: 10.2165/00003495-199142020-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  70 in total

Review 1.  Opioids in chronic pain.

Authors:  H J McQuay
Journal:  Br J Anaesth       Date:  1989-08       Impact factor: 9.166

2.  Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction.

Authors:  G Lee; A N DeMaria; E A Amsterdam; F Realyvasquez; J Angel; S Morrison; D T Mason
Journal:  Am J Med       Date:  1976-06       Impact factor: 4.965

3.  PCA: patient satisfaction, nursing satisfaction and cost-effectiveness.

Authors:  L Jones; J A Neiswender; M Perkins
Journal:  Nurs Manage       Date:  1989-01

4.  An approach to the measurement of the pain and anxiety responses of surgical patients.

Authors:  F L Drew; R W Moriarty; A P Shapiro
Journal:  Psychosom Med       Date:  1968 Nov-Dec       Impact factor: 4.312

5.  [Status of postoperative pain therapy in West Germany. Results of a representative survey].

Authors:  K A Lehmann; C Henn
Journal:  Anaesthesist       Date:  1987-08       Impact factor: 1.041

6.  Reduction of postoperative morbidity following patient-controlled morphine.

Authors:  T J Wasylak; F V Abbott; M J English; M E Jeans
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

7.  Narcotic addiction in patients with chronic pain.

Authors:  P J Evans
Journal:  Anaesthesia       Date:  1981-06       Impact factor: 6.955

8.  Pronounced, episodic oxygen desaturation in the postoperative period: its association with ventilatory pattern and analgesic regimen.

Authors:  D M Catley; C Thornton; C Jordan; J R Lehane; D Royston; J G Jones
Journal:  Anesthesiology       Date:  1985-07       Impact factor: 7.892

9.  The multidimensional nature of cancer-related pain.

Authors:  T A Ahles; E B Blanchard; J C Ruckdeschel
Journal:  Pain       Date:  1983-11       Impact factor: 6.961

10.  Clinical pharmacokinetics applied to patients with intractable pain: studies with pethidine.

Authors:  Christopher J Glynn; Laurence E Mather
Journal:  Pain       Date:  1982-07       Impact factor: 6.961

View more
  18 in total

Review 1.  Adverse effects of systemic opioid analgesics.

Authors:  S A Schug; D Zech; S Grond
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

2.  Patient autonomy as the prerequisite for care: opioids for chronic pain of non-malignant origin.

Authors:  S C Tourigny
Journal:  Health Care Anal       Date:  1995-11

3.  Efficacy of preventive analgesia with tramadol or lornoxicam for percutaneous nephrolithotomy: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Kenan Kaygusuz; Gokhan Gokce; Iclal Ozdemir Kol; Semih Ayan; Sinan Gursoy
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

4.  [The role of morphine-6-glucuronide during longterm administration of morphine.].

Authors:  M Prokopek; A Ziegler
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

Review 5.  Analgesia in the elderly. Practical treatment recommendations.

Authors:  M P Drage; S A Schug
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

6.  Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis.

Authors:  Gabriel Herrero-Beaumont; Olav Bjorneboe; Ute Richarz
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

7.  Legal opioid consumption in Denmark 1981-1993.

Authors:  T Groth Clausen; J Eriksen; F M Borgbjerg
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics.

Authors:  A E Eggen; M Andrew
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 chinese cancer patients.

Authors:  Yu-Lin Zhu; Guo-Hong Song; Duan-Qi Liu; Xi Zhang; Kui-Feng Liu; Ai-Hua Zang; Ying Cheng; Guo-Chun Cao; Jun Liang; Xue-Zhen Ma; Xin Ding; Bin Wang; Wei-Lian Li; Zuo-Wei Hu; Gang Feng; Jiang-Jin Huang; Xiao Zheng; Shun-Chang Jiao; Rong Wu; Jun Ren
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

Review 10.  Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.

Authors:  G K Gourlay
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.